Insights on adaptive and innate immunity in canine leishmaniosis
- PMID: 27094260
- PMCID: PMC5264656
- DOI: 10.1017/S003118201600055X
Insights on adaptive and innate immunity in canine leishmaniosis
Abstract
Canine leishmaniosis (CanL) is caused by the parasite Leishmania infantum and is a systemic disease, which can present with variable clinical signs, and clinicopathological abnormalities. Clinical manifestations can range from subclinical infection to very severe systemic disease. Leishmaniosis is categorized as a neglected tropical disease and the complex immune responses associated with Leishmania species makes therapeutic treatments and vaccine development challenging for both dogs and humans. In this review, we summarize innate and adaptive immune responses associated with L. infantum infection in dogs, and we discuss the problems associated with the disease as well as potential solutions and the future direction of required research to help control the parasite.
Keywords: Canine leishmaniosis; T-cell mediated immunity; cytokine profiles; immunology; toll-like receptors.
References
-
- Abdalmaula G. H., Barbadoro P., Marigliano A., Illuminati D., Di Stanislao F., D'Errico M. M. and Prospero E. (2013). Human visceral leishmaniasis: a picture from Italy. Journal of Infection and Public Health 6, 465–472. - PubMed
-
- Alexander B. and Maroli M. (2003). Control of phlebotomine sandflies. Medical and Veterinary Entomology 17, 1–18. - PubMed
-
- Alexander J. and Bryson K. (2005). T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunology Letters 99, 17–23. - PubMed
-
- Alexander J., Satoskar A. R. and Russell D. G. (1999). Leishmania species: models of intracellular parasitism. Journal of Cell Science 112 (Pt 18), 2993–3002. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical